Rubius Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Rubius Therapeutics, Inc. annual/quarterly Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2022.
  • Rubius Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2022 was 90.4M shares, a 0.62% increase year-over-year.
  • Rubius Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 90.3M shares, a 2.68% increase from 2021.
  • Rubius Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 88M shares, a 9.09% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 90.4M +557K +0.62% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 90.3M +740K +0.83% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q3 2021 89.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 89.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.